Report Highlights
The global catheter market was $17.0 billion in 2010 and $21.2 billion in 2011. This global market is projected to increase at a compound annual growth rate (CAGR) of 8.7% reaching a value of $32.1 billion by 2016.
SCOPE OF REPORT
BCC investigated the current catheter market and based projections of total, geographic, and type of product market revenues through 2016 based on current and historical usage, geographical and socio/economic market trends, and new applications and products.
The scope of this study encompasses the six major application segments of the catheter market. BCC Research analyzes each type of catheter segment, determines its current market status, examines its impact on future markets, and presents growth forecasts over the next five years. Catheter material analysis, regulatory issues, and the latest technological trends are also covered. Other influential factors such as patents and company profiles are discussed.
ANALYST CREDENTIALS
Peggy S. Lehr is the BCC Research analyst of this report. Ms. Lehr has worked with the publishing arms of for-profit and not-for-profit organizations, and she specializes in marketing reports on the medical industry.
Report Highlights
- The global catheter market amounted to $14.5 billion in 2008, and was projected to increase to nearly $18 billion in 2009. It is expected to reach $32.1 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 12.3%.
- The market’s cardiovascular segment is the largest with sales of $6 billion in 2008. That is projected to increase to $7.1 billion in 2009, and to rise at a CAGR of 10.2% to $11.6 billion in 2014.
- The second-largest segment is urology, with revenue of $4.4 billion in 2008, which is expected to reach nearly $6 billion in 2009, and increase to $13.2 billion in 2014, for the highest CAGR among all segments at 17.1%.
Report Highlights
-
The global catheter market is estimated at $13.0 billion for 2007 and forecast to grow at a compound annual growth rate (CAGR) of 8.3% to reach $19.4 billion by 2012.
-
Urologic catheters and diagnostic cardiovascular catheters especially will drive growth within the catheter market.
-
Growth potential in the neurovascular market is strong and waiting to be explored. This market is projected to grow at a CAGR of 9.1% during the forecast period to reach $2.2 billion by 2012.
Report Highlights
-
Fueled by stent revenues, U.S. catheter market sales were forecast to exceed $13.1 billion in 2003. Rising at an AAGR (average annual growthrate) of 12.3%, the market is expected to exceed $23 billion in 2009.
-
Coronary catheter applications should pass $8.2 billion in 2009 with 64% of the projected revenue expected from the sale of drug-elutingstents.
-
Approximately 50% of U.S. catheter production is exported. Roughly 50% of exports go to Europe and 30% go to Japan.
-
Approximately 50% of U.S. catheter production is exported. Roughly 50% of exports go to Europe and 30% go to Japan.
- U.S. companies received more than 63% of recently granted patents.
Related Reports
The Market for Minimally Invasive Medical Devices
The global market for MIS devices and instruments was worth an estimated $13.4 billion in 2010. The market is expected to reach $14.4 billion in 2011 and $21.1 billion by 2016, a compound annual growth rate (CAGR) of 7.9% between 2011 and 2016.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More